Safety Findings of Long-Term Bevacizumab for Patients with Ovarian Cancer Targeted Oncology 1:15 6 years ago 957 Скачать Далее
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer OncLive 1:05 6 years ago 138 Скачать Далее
Dr. Mirza on Safety Profile of Niraparib/Bevacizumab in Recurrent Ovarian Cancer OncLive 0:52 3 years ago 109 Скачать Далее
Dr. Essel Discusses Adverse Events of Bevacizumab in Ovarian Cancer OncLive 1:19 6 years ago 596 Скачать Далее
Bevacizumab for the treatment of patients with ovarian cancer exhibiting poor chemosensitivity VJOncology 0:47 2 years ago 756 Скачать Далее
Dr. Hardesty on Bevacizumab/PARP Inhibitor Combination in Ovarian Cancer OncLive 1:40 5 years ago 264 Скачать Далее
The effectiveness of bevacizumab (Avastin) and related trials Ovacome - the ovarian cancer charity 57:47 2 years ago 4 281 Скачать Далее
Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer ecancer 6:39 5 years ago 1 065 Скачать Далее
Dr. Gilbert on the Safety Profile of Mirvetuximab Soravtansine/Bevacizumab in Ovarian Cancer OncLive 1:59 4 years ago 414 Скачать Далее
GOG-0218: which patients with ovarian cancer experience highest benefit from 1L bevacizumab? VJOncology 3:47 2 years ago 632 Скачать Далее
AGO-OVAR 2.29/ENGOT-ov34: atezolizumab vs placebo + bevacizumab w/ chemo recurrent ovarian cancer VJOncology 6:10 2 months ago 46 Скачать Далее
Ovarian Cancer: Maintenance Following Frontline Bevacizumab OncLive 7:24 4 years ago 272 Скачать Далее
The PAOLA-1 study: olaparib and bevacizumab for ovarian cancer VJOncology 2:27 5 years ago 1 368 Скачать Далее
Results for Combination Bevacizumab Plus Mirvetuximab Soravtansine in Ovarian Cancer Targeted Oncology 0:45 5 years ago 230 Скачать Далее
Ovarian Cancer: Standards of Care and New Opportunities - Dr. Robert Coleman HMP Education 33:15 11 years ago 1 400 Скачать Далее
